Compare CRBP & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBP | MED |
|---|---|---|
| Founded | 2009 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.8M | 120.6M |
| IPO Year | 2014 | 1996 |
| Metric | CRBP | MED |
|---|---|---|
| Price | $7.63 | $10.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | ★ $50.29 | $12.00 |
| AVG Volume (30 Days) | 138.7K | ★ 244.2K |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,822,272.00 | ★ $934,842,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $220.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 97.62 | N/A |
| 52 Week Low | $4.64 | $10.10 |
| 52 Week High | $20.56 | $15.37 |
| Indicator | CRBP | MED |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 39.17 |
| Support Level | $6.73 | $10.23 |
| Resistance Level | $8.43 | $12.21 |
| Average True Range (ATR) | 0.47 | 0.42 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 38.50 | 34.44 |
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.